Tiny blood test could unlock IVF pregnancy dangers

NCT ID NCT07477340

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at a hormone called relaxin in women who get pregnant through IVF. Researchers want to see if relaxin levels differ between fresh and frozen embryo transfers, and if low levels are linked to pregnancy complications. 60 first-time mothers will give an extra blood sample early in pregnancy. The goal is to learn why frozen embryo transfers may carry higher risks of conditions like preeclampsia.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Relaxin measurement (blood test)
What this could lead to
If successful, this could help explain why some IVF pregnancies have higher risks of complications like preeclampsia, and may guide safer embryo transfer methods.
What could go wrong
This is a small, early observational study (60 people) that only measures a hormone level. It won't directly change treatment or prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EMBRYOS TRANSFERT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Service de Médecine et de la Reproduction HFME

    Bron, Rhone, 69500, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.